246 related articles for article (PubMed ID: 30124476)
1. Age-related clonal hematopoiesis: implications for hematopoietic stem cell transplantation.
Abelson S; Wang JCY
Curr Opin Hematol; 2018 Nov; 25(6):441-445. PubMed ID: 30124476
[TBL] [Abstract][Full Text] [Related]
2. Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.
Williams LS; Williams KM; Gillis N; Bolton K; Damm F; Deuitch NT; Farhadfar N; Gergis U; Keel SB; Michelis FV; Panch SR; Porter CC; Sucheston-Campbell L; Tamari R; Stefanski HE; Godley LA; Lai C
Transplant Cell Ther; 2024 Mar; 30(3):255-267. PubMed ID: 37913908
[TBL] [Abstract][Full Text] [Related]
3. Clonal hematopoiesis in hematopoietic stem cell transplantation.
Wilk CM; Manz MG; Boettcher S
Curr Opin Hematol; 2021 Mar; 28(2):94-100. PubMed ID: 33394723
[TBL] [Abstract][Full Text] [Related]
4. Age-related clonal hematopoiesis.
Shlush LI
Blood; 2018 Feb; 131(5):496-504. PubMed ID: 29141946
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
6. The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation.
Nawas MT; Schetelig J; Damm F; Levine RL; Perales MA; Giralt SA; VanDenBrink MR; Arcila ME; Zehir A; Papaemmanuil E; Klussmeier A; Schmidt AH; Maiwald S; Bolton KL; Tamari R
Blood Rev; 2021 Mar; 46():100744. PubMed ID: 32896435
[TBL] [Abstract][Full Text] [Related]
7. Clonal dominance of a donor-derived del(20q) clone after allogeneic hematopoietic stem cell transplantation in an acute myeloid leukemia patient with del(20q).
Yoon J; Yun JW; Jung CW; Kim HJ; Kim SH
J Clin Lab Anal; 2019 Sep; 33(7):e22951. PubMed ID: 31187545
[TBL] [Abstract][Full Text] [Related]
8. Clonal hematopoiesis and its emerging effects on cellular therapies.
von Bonin M; Jambor HK; Teipel R; Stölzel F; Thiede C; Damm F; Kroschinsky F; Schetelig J; Chavakis T; Bornhäuser M
Leukemia; 2021 Oct; 35(10):2752-2758. PubMed ID: 34215849
[TBL] [Abstract][Full Text] [Related]
9. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
Kindwall-Keller TL; Ballen KK
Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
[TBL] [Abstract][Full Text] [Related]
10. Clonal Hematopoiesis and risk of Acute Myeloid Leukemia.
Desai P; Hassane D; Roboz GJ
Best Pract Res Clin Haematol; 2019 Jun; 32(2):177-185. PubMed ID: 31203999
[TBL] [Abstract][Full Text] [Related]
11. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
[TBL] [Abstract][Full Text] [Related]
13. Preleukemia: the normal side of cancer.
Shlush LI; Minden MD
Curr Opin Hematol; 2015 Mar; 22(2):77-84. PubMed ID: 25575035
[TBL] [Abstract][Full Text] [Related]
14. The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases.
Maris M; Storb R
Immunol Res; 2003; 28(1):13-24. PubMed ID: 12947221
[TBL] [Abstract][Full Text] [Related]
15. Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies.
Zhao AT; Sung AD
Curr Oncol Rep; 2022 Jan; 24(1):125-133. PubMed ID: 35061190
[TBL] [Abstract][Full Text] [Related]
16. Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome.
Koreth J; Biernacki M; Aldridge J; Kim HT; Alyea EP; Armand P; Cutler C; Ho VT; Wu CJ; Antin JH; Soiffer RJ
Biol Blood Marrow Transplant; 2011 Mar; 17(3):421-8. PubMed ID: 20870027
[TBL] [Abstract][Full Text] [Related]
17. [Single center comparative analysis of hematopoietic cell transplantation from alternated donor in patients with hematologic malignancies].
Wang J; Zhou J; Zheng HF; Wang PF; Fu CC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):159-65. PubMed ID: 25687066
[TBL] [Abstract][Full Text] [Related]
18. Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia.
Burns SS; Kapur R
Stem Cell Reports; 2020 Aug; 15(2):279-291. PubMed ID: 32783925
[TBL] [Abstract][Full Text] [Related]
19. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
[TBL] [Abstract][Full Text] [Related]
20. Unrelated donor haematopoietic stem cell transplantation for adult patients with haematological malignancies.
Huang H; Lai XY
Hong Kong Med J; 2009 Jun; 15(3 Suppl 3):22-6. PubMed ID: 19494392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
